Quidel Corporation

Grantee Website San Diego, California, United States
Purpose
to develop, manufacture, and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Wildcat MDx platform for limited resource settings.
Division
Global Health
Year Awarded
2012
Region Served
GLOBAL
Committed Amount
$20,912,487
Grant Topic
HIV
Duration (Months)
62
Grantee Location
San Diego, California, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.